Following the UK–China HealthTech Exchange in Birmingham, EFEC CEO Lily Lin reflects on the different challenges facing HealthTech businesses exploring opportunities in the UK and China.
Originally published by Medilink Midlands, the article considers how regulatory requirements, clinical engagement and changing procurement arrangements can influence a company’s route into another healthcare market.
Read the full article on Medilink Midlands → https://www.medilinkmidlands.com/different-routes-to-market-reflections-from-the-uk-china-healthtech-exchange/